Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
48 studies found for:    MPR-1
Show Display Options
Rank Status Study
1 Recruiting NSABP Patient Registry and Biospecimen Profiling Repository
Condition: Colorectal Cancer
Intervention:
2 Completed Bioavailability Study of 3 Tablet Formulations vs. Capsule Formulation of JNJ-56021927 in Fasting Healthy Male Participants
Condition: Healthy
Interventions: Drug: JNJ-56021927 Softgel Capsule;   Drug: JNJ-56021927 Tablet Formulation 1;   Drug: JNJ-56021927 Tablet Formulation 2;   Drug: JNJ-56021927 Tablet Formulation 3
3 Completed
Has Results
Fentanyl Buccal Tablets Versus Immediate Release Oxycodone for Breakthrough Pain in Patients With Chronic Pain
Condition: Chronic Pain
Interventions: Drug: Fentanyl Buccal Tablet;   Drug: Immediate release oxycodone
4 Not yet recruiting Microvascular Disease Exercise Trial
Condition: Coronary Microvascular Disease
Interventions: Behavioral: Exercise Program;   Drug: Medical Therapy
5 Active, not recruiting Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
Conditions: Stage I Multiple Myeloma;   Stage II Multiple Myeloma;   Stage III Multiple Myeloma
Interventions: Drug: melphalan;   Drug: prednisone;   Drug: thalidomide;   Drug: lenalidomide;   Other: quality-of-life assessment;   Other: laboratory biomarker analysis
6 Recruiting Study to Assess Drug-Drug Interaction Between Itraconazole or Gemfibrozil and JNJ-56021927
Condition: Healthy
Interventions: Drug: JNJ-56021927;   Drug: Itraconazole;   Drug: Gemfibrozil
7 Active, not recruiting
Has Results
A Study to Compare MPR With MP in Newly Diagnosed Multiple Myeloma Subjects 65 Years Old or Older.
Condition: Newly Diagnosed Multiple Myeloma
Interventions: Drug: Lenalidomide:  Double-blind Induction;   Drug: Melphalan;   Drug: Prednisone;   Drug: Aspirin;   Drug: Placebo;   Drug: Lenalidomide:  Double-blind Maintenance;   Drug: Lenalidomide:  Open-label
8 Recruiting Genetically Guided Statin Therapy
Conditions: Hypercholesterolemia;   HMG COA Reductase Inhibitor Adverse Reaction
Interventions: Genetic: Reporting for SLCO1B1*5 allele at randomization;   Genetic: Reporting for SLCO1B1*5 allele at the end;   Genetic: Genetic testing for SLCO1B1*5 allele
9 Completed A Study to Assess the Interaction Between ASP1707 and Itraconazole in Healthy Female Subjects
Conditions: Pharmacokinetics;   DDI (Drug-Drug Interaction);   Healthy Subjects
Interventions: Drug: ASP1707;   Drug: itraconazole
10 Recruiting Effectiveness of "Medisinstart"
Condition: Cardiovascular Diseases
Intervention: Other: Medisinstart
11 Completed Study of the Clinical Management of Bipolar Disease
Condition: Bipolar Disorders
Intervention:
12 Recruiting Partners and Alerts: A Study of Social Forces in Medication Adherence
Condition: Acute Myocardial Infarction (AMI)
Interventions: Behavioral: Electronic Pill Bottle tracking;   Behavioral: Adherence Messaging;   Behavioral: Social Influence;   Behavioral: Medication schedule alarms
13 Completed Therapy Optimization in Multiple Sclerosis (MS)
Condition: Multiple Sclerosis
Intervention: Drug: Glatiramer Acetate, IFN-beta 1a (IM), IFN-beta 1a (Subcutaneous), and IFN-beta 1b
14 Active, not recruiting
Has Results
Neo ALTTO (Neoadjuvant Lapatinib and/or Trastuzumab Treatment Optimisation) Study
Condition: Neoplasms, Breast
Interventions: Drug: Lapatinib;   Biological: Trastuzumab;   Drug: Paclitaxel
15 Unknown  Lenalidomide and Dexamethasone Versus Melphalan Prednisone and Lenalidomide Versus Cyclophosphamide, Prednisone and Lenalidomide in Elderly Multiple Myeloma Patients
Condition: Multiple Myeloma
Interventions: Drug: Melphalan, Prednisone, Lenalidomide;   Drug: Cyclophosphamide, Prednisone, Lenalidomide;   Drug: Lenalidomide, dexamethasone
16 Unknown  Study to Demonstrate That Muscle Pattern Recognition (MPR) is an Effective Evaluation Tool for Musculoskeletal Neck or Back Pain
Conditions: Neck Pain;   Low Back Pain
Intervention: Device: Muscle Pattern Recognition (MPR)
17 Terminated Transarterial Chemoembolisation Plus Bevacizumab for Treatment of Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Intervention: Drug: bevacizumab
18 Completed Improving Antipsychotic Adherence Among Patients With Serious Mental Illness
Conditions: Schizophrenia;   Schizoaffective Disorder;   Bipolar Disorder
Interventions: Behavioral: Unit of use medication packaging;   Behavioral: Mailed reminders to patient when medication refills are due;   Behavioral: Note to Mental Health Provider when refill is overdue;   Procedure: Aligning all prescriptions to fall due on same date
19 Completed The Impact of a Brief Educational Intervention on Glaucoma Adherence
Condition: Glaucoma Medication Adherence
Intervention: Behavioral: Glaucoma Educational Intervention
20 Completed The Impact of Legally Enforced Embryo Transfer Policy (Belgian Law 2003) on Cumulative Delivery Rate.
Condition: Impact of Legislation on Cumulative Delivery Rate
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years